Tar Heel Times
Your comprehensive source for Tar Heel sports news

UNC ranked 7th among biomedical research institutions


Researchers at the University of North Carolina at Chapel Hill are using genetically engineered mouse models to help predict how humans will respond to different chemotherapy drug combinations used to fight breast cancer. Last year, UNC scientists identified biomarkers for challenging molecular subtypes of human breast cancer in genetically engineered mice, specifically looking for types that have few known targets and available therapies. (Fierce Biotech Research)


Related:

Share: Facebook | Twitter | Email

Recent Campus Connections News:

Carolina receives $10 million commitment from the Pope Foundation

Chapel Hill's oldest bar, The Cave, to close

Delany family gives $1 million gift to the Carolina Edge initiative

Who killed Faith Hedgepeth? Crime show investigates unsolved Chapel Hill slaying.

UNC Graduates Win Pulitzer Prizes

Climbing the bell tower with the Class of 2018


© 2005-2018 Tar Heel Times | Contact | Privacy Policy | Site Map | RSS | Did UNC Win?

Tar Heel Times is an unofficial resource for UNC fans and is not affiliated with the University of North Carolina.